Adrenal gland tumor

  • Feb 20, 2018 www.medscape.com
    When Missing a ‘Zebra’ Can Land You in Court – Medscape
    Read More
  • Feb 11, 2018 www.urotoday.com
    ASCO GU 2018: Management of Adrenocortical Carcinoma and Pheochromocytoma Endocrinologic Issues – UroToday
    Read More
  • Feb 11, 2018 www.urotoday.com
    ASCO GU 2018: Management of Metastatic Disease for Adrenocortical Carcinoma and Pheochromocytoma – UroToday
    Read More
  • Omani boy undergoes rare surgery at KIMS – The New Indian Express
    Read More
  • Feb 06, 2018 www.onclive.com
    Kulke Sheds Light on Emerging Agents for Neuroendocrine Tumors – OncLive
    Read More
  • Feb 01, 2018 globenewswire.com
    Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting – GlobeNewswire
    Read More
  • Jan 02, 2018 www.targetedonc.com
    Novel Iobenguane I-131 Agent Granted FDA’s Priority Review for Rare Neuroendocrine Tumors – Targeted Oncology
    Read More
  • Dec 29, 2017 www.onclive.com
    FDA Grants Priority Review to Novel Iobenguane I-131 Agent for Rare Neuroendocrine Tumors – OncLive
    Read More
  • Dec 29, 2017 globenewswire.com
    Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA® (iobenguane I 131) in Pheochromocytoma and Paraganglioma – GlobeNewswire
    Read More

Connect. Empower. Inspire.